The diagnostic and therapeutic achievements in radiopharmaceuticals and nuclear medicine instrumentation – PET, SPECT, MR, CT and their hypbrids PET-CT and SPECT-CT – are the result of the interdisciplinary research efforts of cell-biologists, chemists, pharmacologists, physicists, computer-scientists, engineers, nuclear medicine physicians, and oncologists. The clinical implications of the…